Zobrazeno 1 - 10
of 1 572
pro vyhledávání: '"Griffin, K."'
Autor:
Andrew V. Tran, John K. Stadler, Zachary Ernst, Caleb A. Smith, Danya Nees, Griffin K. Hughes, Matt Vassar
Publikováno v:
BMC Neurology, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background Neurological disorders have had a substantial rise the last three decades, imposing substantial burdens on both patients and healthcare costs. Consequently, the demand for high-quality research has become crucial for exploring eff
Externí odkaz:
https://doaj.org/article/1e0426862d4e41fcbf7ae0fff8220469
Autor:
Rao, M. P., Cook, B. I., Cook, E. R., D'Arrigo, R. D., Krusic, P. J., Anchukaitis, K. J., LeGrande, A. N., Buckley, B. M., Davi, N. K., Leland, C., Griffin, K. L.
Volcanic eruptions have global climate impacts, but their effect on the hydrologic cycle is poorly understood. We use a modified version of superposed epoch analysis, an eruption year list collated from multiple data sets, and seasonal paleoclimate r
Externí odkaz:
http://hdl.handle.net/10150/625048
http://arizona.openrepository.com/arizona/handle/10150/625048
http://arizona.openrepository.com/arizona/handle/10150/625048
Autor:
Alex Hagood, Logan Patrick Corwin, Jay S. Modi, Garrett A. Jones, Kyle J. Fitzgerald, Kimberly J. Magana, Shaelyn A. Ward, Trevor R. Magee, Griffin K. Hughes, Alicia Ito Ford, Matt Vassar
Publikováno v:
Contemporary Clinical Trials Communications, Vol 41, Iss , Pp 101347- (2024)
Main problem: Chronic kidney disease (CKD) is a progressive condition that affects millions of people worldwide. A standardized core outcome set (COS) was developed for CKD by the International Consortium for Health Outcomes and Measurements in 2019.
Externí odkaz:
https://doaj.org/article/36b5e03caf5c4a16835ae099970f5eb1
Autor:
Matt Vassar, Vinay Prasad, Ryan McIntire, Alyson Haslam, Brody Dennis, Chance Bratten, Griffin K Hughes, Andriana M Peña, Chase Ladd, Brooke Gardner, William Nowlin, Reagan Livingston, Jordan Tuia
Publikováno v:
BMJ Oncology, Vol 3, Iss 1 (2024)
Objective Our objective of this study was to analyse all oncological clinical trials using regorafenib to create a complete risk/benefit profile for the drug.Background Creating a novel chemotherapy is costly both in time and capital spent for drug m
Externí odkaz:
https://doaj.org/article/7ca47621bd2a46d6b44ec10b8d27ec8d
Autor:
Hagood, Alex, Corwin, Logan Patrick, Modi, Jay S., Jones, Garrett A., Fitzgerald, Kyle J., Magana, Kimberly J., Ward, Shaelyn A., Magee, Trevor R., Hughes, Griffin K., Ford, Alicia Ito, Vassar, Matt
Publikováno v:
In Contemporary Clinical Trials Communications October 2024 41
Autor:
Hunter Hall, Rafe, Wright, Carson L., Hughes, Griffin K., Peña, Andriana M., Ladd, Chase, Gardner, Brooke, McIntire, Ryan, Ferrell, Matt, Rubenstein, Jane, Tuia, Jordan, Haslam, Alyson, Prasad, Vinay, Vassar, Matt
Publikováno v:
In Clinical Therapeutics June 2024 46(6):e107-e113
Autor:
Adam Khan, Hassan Khan, Griffin K. Hughes, Chase Ladd, Ryan McIntire, Brooke Gardner, Andriana M. Peña, Abigail Schoutko, Jordan Tuia, Kirstien Minley, Alyson Haslam, Vinay Prasad, Matt Vassar
Publikováno v:
Cancer Medicine, Vol 13, Iss 9, Pp n/a-n/a (2024)
Abstract Objective This study aims to evaluate published clinical trials of ramucirumab to assess the risk/benefit profile and burden over time for patients. Background The burden of oncologic drug development on patients paired with increasing clini
Externí odkaz:
https://doaj.org/article/f7f50920e6bb409a822baf9cf0fba3d2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Peter Mikula, Oldřich Tomášek, Dušan Romportl, Timothy K. Aikins, Jorge E. Avendaño, Bukola D. A. Braimoh-Azaki, Adams Chaskda, Will Cresswell, Susan J. Cunningham, Svein Dale, Gabriela R. Favoretto, Kelvin S. Floyd, Hayley Glover, Tomáš Grim, Dominic A. W. Henry, Tomas Holmern, Martin Hromada, Soladoye B. Iwajomo, Amanda Lilleyman, Flora J. Magige, Rowan O. Martin, Marina F. de A. Maximiano, Eric D. Nana, Emmanuel Ncube, Henry Ndaimani, Emma Nelson, Johann H. van Niekerk, Carina Pienaar, Augusto J. Piratelli, Penny Pistorius, Anna Radkovic, Chevonne Reynolds, Eivin Røskaft, Griffin K. Shanungu, Paulo R. Siqueira, Tawanda Tarakini, Nattaly Tejeiro-Mahecha, Michelle L. Thompson, Wanyoike Wamiti, Mark Wilson, Donovan R. C. Tye, Nicholas D. Tye, Aki Vehtari, Piotr Tryjanowski, Michael A. Weston, Daniel T. Blumstein, Tomáš Albrecht
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-10 (2023)
Abstract Animal tolerance towards humans can be a key factor facilitating wildlife–human coexistence, yet traits predicting its direction and magnitude across tropical animals are poorly known. Using 10,249 observations for 842 bird species inhabit
Externí odkaz:
https://doaj.org/article/e023202530c94206b060ac9b2028e0cb